valrubicin
valrubicin is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Valstar. Available dosage form: solution, concentrate.
Drug Details
- Generic Name
- valrubicin
- Brand Names
- Valstar
- Application Number
- NDA020892
- Sponsor
- Endo USA, Inc.
- NDC Codes
- 1
- Dosage Forms
- SOLUTION, CONCENTRATE
- Routes
- INTRAVESICAL
- Active Ingredients
- VALRUBICIN
Indications and Usage
1 INDICATIONS AND USAGE Valrubicin intravesical solution is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality. • Valrubicin intravesical solution is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality. ( 1 )